person · Reporting owner
Aronson Martha Goldberg
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Director | June 02, 2025 | June 04, 2025 |
| MERIT MEDICAL SYSTEMS INCMMSI · Entity 3858 | Director · President and CEO | May 06, 2026 | May 07, 2026 |
| METHODE ELECTRONICS INCMEI · Entity 1870 | Director | July 02, 2019 | July 08, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date June 02, 2025 · Filed June 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,391 |
Reported balance
After 2025-06-03 transaction · row 1
1 source rowRow 1 · 2025-06-03 · Exercise / conversion · Acquired 479 · Balance 12,391 |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $55.38 · Expires 2035-06-02 | Direct | 8,061 |
Reported balance
After 2025-06-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-06-02 · Grant · Acquired 8,061 · Balance 8,061 F1: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2035-06-02 | Direct | 668 |
Reported balance
After 2025-06-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-06-02 · Grant · Acquired 668 · Balance 668 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |
| RSUs (Restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2034-06-03 | Direct | 0 |
Reported balance
After 2025-06-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-06-03 · Exercise / conversion · Disposed 479 · Balance 0 F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. |
| Common StockSEC Table I · non-derivative | Indirectby IRA | 2,000 |
Reported balance
Holding disclosure · report date 2025-06-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
MERIT MEDICAL SYSTEMS INC
Report date May 06, 2026 · Filed May 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, No Par ValueSEC Table I · non-derivative | Direct | 49,792 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Purchase · Acquired 2,000 · Balance 49,792 |
METHODE ELECTRONICS INC
Report date July 02, 2019 · Filed July 08, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,000 |
Reported balance
After 2019-07-02 transaction · row 1
1 source rowRow 1 · 2019-07-02 · Grant · Acquired 3,000 · Balance 12,000 F1: Restricted Stock Award granted under terms of the Methode Electronics, Inc. 2014 Stock Plan |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Award granted under terms of the Methode Electronics, Inc. 2014 Stock Plan
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Cardiovascular Systems Inc
Report date April 27, 2023 · Filed April 27, 2023
Section 16 reporting ended · disclosed 2023-04-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-04-27 transaction · row 1
1 source rowRow 1 · 2023-04-27 · Disposition to issuer · Disposed 12,411 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of common stock converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-04-27 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-04-27 · Disposition to issuer · Disposed 29,816 · Balance 0 F2: Pursuant to the Merger Agreement, each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of common stock converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes.
F2: Pursuant to the Merger Agreement, each unvested restricted stock unit became fully vested immediately prior to the effective time of the merger. Restricted stock units were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes.
HUTCHINSON TECHNOLOGY INC
Report date October 05, 2016 · Filed October 05, 2016
Section 16 reporting ended · disclosed 2016-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Martha G. Aronson Revocable Trust | 0 |
Reported balance
After 2016-10-05 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2016-10-05 · Disposition to issuer · Disposed 50,000 · Balance 0 F1: Price reflects per share consideration paid pursuant to the Agreement and Plan of Merger, dated November 1, 2015 (the "Merger Agreement"), by and among Hutchinson Technology Incorporated, Headway Technologies, Inc. and Hydra Merger Sub, Inc. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.51 · Expires 2020-06-02 | Direct | 0 |
Reported balance
After 2016-10-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F2: These stock options, which provided for vesting in two equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.34 · Expires 2021-01-20 | Direct | 0 |
Reported balance
After 2016-10-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-10-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F3: These stock options, which provided for vesting in two equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.53 · Expires 2022-01-25 | Direct | 0 |
Reported balance
After 2016-10-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-10-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F4: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.82 · Expires 2023-01-30 | Direct | 0 |
Reported balance
After 2016-10-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2016-10-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F5: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.88 · Expires 2024-01-30 | Direct | 0 |
Reported balance
After 2016-10-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2016-10-05 · Disposition to issuer · Disposed 5,000 · Balance 0 F6: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.50 · Expires 2025-01-29 | Direct | 0 |
Reported balance
After 2016-10-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2016-10-05 · Disposition to issuer · Disposed 10,000 · Balance 0 F7: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Price reflects per share consideration paid pursuant to the Agreement and Plan of Merger, dated November 1, 2015 (the "Merger Agreement"), by and among Hutchinson Technology Incorporated, Headway Technologies, Inc. and Hydra Merger Sub, Inc.
F2: These stock options, which provided for vesting in two equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement.
F3: These stock options, which provided for vesting in two equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest.
F4: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest.
F5: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest.
F6: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest.
F7: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2018 Filed Jun 4, 2018 20:58 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,629 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019793 · form4.xml · derivative · entry 3 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,629 Underlying: Common Stock · 1,629 shares Expires 2028-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:58 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019793 · form4.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2018 Filed Jun 4, 2018 20:58 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-019793 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 16:40 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantRestricted Stock Units · Derivative | 4,029 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-17-000231 · edgar.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,029 Underlying: Common Stock · 4,029 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,008 shares on September 30, 2017 and 1,007 shares on each of December 31, 2017, March 31, 2018 and June 30, 2018. F3 · derivative.exercise_date: Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,008 shares on September 30, 2017 and 1,007 shares on each of December 31, 2017, March 31, 2018 and June 30, 2018. F3 · derivative.expiration_date: Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,008 shares on September 30, 2017 and 1,007 shares on each of December 31, 2017, March 31, 2018 and June 30, 2018. Read SEC document |
| July 11, 2017 Filed Jul 13, 2017 13:02 UTC | METHODE ELECTRONICS INC MEI · Entity 1870 | GrantCommon Stock | 3,000 | $40.30 | $120,900.00 |
DisclosureSEC source: 0001209191-17-044979 · doc4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:18 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 3,669 | $51.90 Strike: $51.90 | $190,421.10 |
DisclosureSEC source: 0001127602-17-020262 · form4.xml · derivative · entry 4 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,669 Underlying: Common Stock · 3,669 shares Expires 2027-06-01 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:18 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 2,167 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020262 · form4.xml · derivative · entry 3 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2027-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 2,739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020262 · form4.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,739 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 19:18 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 2,739 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020262 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 22:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008622 · form4.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 22:00 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 1,000 | $41.71 | $41,710.00 |
DisclosureSEC source: 0001127602-17-008622 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 16:37 UTC | Cardiovascular Systems Inc CSII · Entity 114141 | GrantRestricted Stock Units · Derivative | 1,633 | $0.00 | $0.00 |
DisclosureSEC source: 0000914190-17-000068 · edgar.xml · derivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,633 Underlying: Common Stock · 1,633 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and will be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in amounts of 408 shares on March 31, 2017 and 1,225 shares on June 30, 2017. F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and will be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in amounts of 408 shares on March 31, 2017 and 1,225 shares on June 30, 2017. F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and will be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in amounts of 408 shares on March 31, 2017 and 1,225 shares on June 30, 2017. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 14:44 UTC | HUTCHINSON TECHNOLOGY INC HTCH · Entity 181801 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001127602-16-064288 · form4.xml · derivative · entry 7 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2025-01-29 F7 · derivative.exercise_date: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 14:44 UTC | HUTCHINSON TECHNOLOGY INC HTCH · Entity 181801 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.88 | $0.00 |
DisclosureSEC source: 0001127602-16-064288 · form4.xml · derivative · entry 6 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2024-01-30 F6 · derivative.exercise_date: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 14:44 UTC | HUTCHINSON TECHNOLOGY INC HTCH · Entity 181801 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $2.82 | $0.00 |
DisclosureSEC source: 0001127602-16-064288 · form4.xml · derivative · entry 5 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-01-30 F5 · derivative.exercise_date: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 14:44 UTC | HUTCHINSON TECHNOLOGY INC HTCH · Entity 181801 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001127602-16-064288 · form4.xml · derivative · entry 4 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-01-25 F4 · derivative.exercise_date: These stock options, which provided for vesting in three equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 14:44 UTC | HUTCHINSON TECHNOLOGY INC HTCH · Entity 181801 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.34 | $0.00 |
DisclosureSEC source: 0001127602-16-064288 · form4.xml · derivative · entry 3 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-01-20 F3 · derivative.exercise_date: These stock options, which provided for vesting in two equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement in exchange for a cash payment of $4.00 less the per share exercise price multiplied by the number of unexercised options, without interest. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 14:44 UTC | HUTCHINSON TECHNOLOGY INC HTCH · Entity 181801 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0001127602-16-064288 · form4.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2020-06-02 F2 · derivative.exercise_date: These stock options, which provided for vesting in two equal installments beginning on the first anniversary of the date of grant, were canceled pursuant to the terms of the Merger Agreement. Read SEC document |
| October 05, 2016 Filed Oct 5, 2016 14:44 UTC | HUTCHINSON TECHNOLOGY INC HTCH · Entity 181801 | Disposition to issuerCommon Stock | 50,000 | $4.00 | $200,000.00 |
DisclosureSEC source: 0001127602-16-064288 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Martha G. Aronson Revocable Trust Disclosed balance after: 0 F1 · price: Price reflects per share consideration paid pursuant to the Agreement and Plan of Merger, dated November 1, 2015 (the "Merger Agreement"), by and among Hutchinson Technology Incorporated, Headway Technologies, Inc. and Hydra Merger Sub, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.